EPILEPTIC ENCEPHALOPATHY
Clinical trials for EPILEPTIC ENCEPHALOPATHY explained in plain language.
Never miss a new study
Get alerted when new EPILEPTIC ENCEPHALOPATHY trials appear
Sign up with your email to follow new studies for EPILEPTIC ENCEPHALOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare seizure patients: Long-Term drug safety confirmed
Disease control CompletedThis study looked at the long-term safety of a drug called fenfluramine (ZX008) for people with rare seizure disorders like Dravet syndrome and Lennox-Gastaut syndrome. A total of 412 participants who had completed earlier studies took the drug and were monitored for side effects…
Matched conditions: EPILEPTIC ENCEPHALOPATHY
Phase: PHASE3 • Sponsor: Zogenix, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New hope for kids with rare sleep epilepsy?
Disease control CompletedThis study tested a drug called NBI-827104 in 24 children with a rare epilepsy that causes constant brain spikes during sleep. The drug is a calcium channel blocker given daily for 13 weeks. The main goal was to see if it reduces abnormal brain activity measured by EEG.
Matched conditions: EPILEPTIC ENCEPHALOPATHY
Phase: PHASE2 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated Jun 26, 2026 13:48 UTC
-
New gene test could unlock mysteries of severe epilepsy in kids
Diagnosis CompletedThis study tested whether a powerful genetic test called exome sequencing can find the cause of severe epilepsy in children when standard tests fail. Researchers studied 15 children with epileptic encephalopathy of unknown genetic origin. The goal was to see if this test could im…
Matched conditions: EPILEPTIC ENCEPHALOPATHY
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
Liquid vs. pill: new study tests easier way to take seizure drug
Knowledge-focused CompletedThis study tested two versions of the seizure medication stiripentol (Diacomit®) in 24 healthy adults: a capsule and a liquid suspension. The goal was to see if the liquid form is absorbed by the body in a similar way to the capsule. If so, it could provide a more convenient opti…
Matched conditions: EPILEPTIC ENCEPHALOPATHY
Phase: PHASE1 • Sponsor: Biocodex • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:16 UTC